Loading…

Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study

Background & Aims Nitric oxide, a major inhibitory nonadrenergic, noncholinergic neurotransmitter that relaxes smooth muscle, may be implicated in the pathophysiology of visceral hypersensitivity in irritable bowel syndrome (IBS). Impaired bioavailability of the nitric oxide precursor molecule L...

Full description

Saved in:
Bibliographic Details
Published in:United European gastroenterology journal 2021-09, Vol.9 (7), p.809-818
Main Authors: McEvoy, Mark A., Attia, John R., Oldmeadow, Christopher, Holliday, Elizabeth, Smith, Wayne T., Mangoni, Arduino A., Peel, Roseanne, Hancock, Stephen J., Walker, Marjorie M., Talley, Nicholas J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5157-9c6defb3c0aac5b3248618f905b3d938fafdb02f9c06da89711a7be2c9f81b1f3
cites cdi_FETCH-LOGICAL-c5157-9c6defb3c0aac5b3248618f905b3d938fafdb02f9c06da89711a7be2c9f81b1f3
container_end_page 818
container_issue 7
container_start_page 809
container_title United European gastroenterology journal
container_volume 9
creator McEvoy, Mark A.
Attia, John R.
Oldmeadow, Christopher
Holliday, Elizabeth
Smith, Wayne T.
Mangoni, Arduino A.
Peel, Roseanne
Hancock, Stephen J.
Walker, Marjorie M.
Talley, Nicholas J.
description Background & Aims Nitric oxide, a major inhibitory nonadrenergic, noncholinergic neurotransmitter that relaxes smooth muscle, may be implicated in the pathophysiology of visceral hypersensitivity in irritable bowel syndrome (IBS). Impaired bioavailability of the nitric oxide precursor molecule L‐arginine and higher concentrations of methylarginines (endogenous inhibitors of nitric oxide synthesis) are known to impair nitric oxide synthesis in numerous gastrointestinal cell types. We therefore examined serum concentrations of L‐arginine and the methylarginines in a nested case‐control study, to assess whether these factors are associated with adult IBS. Methods Data on clinical characteristics, methylarginines, and L‐arginine (measured using LC‐MS/MS) were collected from a random population‐based cohort of Australian adults (median age = 64 years; IQR = 60–70). Cases of IBS, defined according to Rome III criteria (N = 156), and controls (N = 332) were identified from within the cohort at the 5‐year follow‐up. Results In adjusted logistic regression analyses, L‐arginine, asymmetric dimethylarginine, symmetric dimethylarginine, L‐arginine/asymmetric dimethylarginine ratio, and Kessler‐10 psychological distress scores were significantly associated with IBS (p > 0.05). Similar results were found for IBS subtypes. Higher serum L‐arginine concentration had the strongest association with IBS diagnosis, with an odds ratio of 9.03 for those with serum L‐arginine at the 75th (84 μmol/L) versus 25th (46 μmol/L) percentile (95% CI: 5.99–13.62). L‐arginine had the best discriminative ability with a bias‐adjusted area under the receiver operator characteristic curve of 0.859. Conclusions Higher serum concentrations of L‐arginine and endogenous methylarginines are strongly associated with IBS in adults.
doi_str_mv 10.1002/ueg2.12137
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8435254</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3090900095</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5157-9c6defb3c0aac5b3248618f905b3d938fafdb02f9c06da89711a7be2c9f81b1f3</originalsourceid><addsrcrecordid>eNp9kc9qFTEUxoMottRufAAJuBHh1iST-RMXQim1LVxwoV2HTHLmNiWTXJOMZXauXfkIPouP4pOYdurFujBZ5MD58Z3z5UPoOSVHlBD2ZoINO6KMVu0jtM9ITVYNp_zxribNHjpM6ZqU03WcMf4U7VWcV7Sh9T769hHiNOL1r6_fVdxYbz1g5Q0Gb8IGfJgSHiFfzW7X1cFr8DmqbINPeBvBWJ2xjdFm1TvAfbgBh9PsTQwjYOuxMpPL6S0-_vnDQ8pgsFYJysiilWMocJ7M_Aw9GZRLcHj_HqDL96efTs5X6w9nFyfH65Wuad2uhG4MDH2liVK67ivGu4Z2gyClNqLqBjWYnrBBaNIY1YmWUtX2wLQYOtrToTpA7xbd7dSPYBYzTm6jHVWcZVBWPux4eyU34YvseFWzmheBV_cCMXyeiiE52qTBOeWhfJhkdcN5J1jbFPTlP-h1mKIv9mRFRLmEiLpQrxdKx5BShGG3DCXyNmV5m7K8S7nAL_5ef4f-ybQAdAFurIP5P1Ly8vSMLaK_AdVruJo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3090900095</pqid></control><display><type>article</type><title>Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study</title><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>McEvoy, Mark A. ; Attia, John R. ; Oldmeadow, Christopher ; Holliday, Elizabeth ; Smith, Wayne T. ; Mangoni, Arduino A. ; Peel, Roseanne ; Hancock, Stephen J. ; Walker, Marjorie M. ; Talley, Nicholas J.</creator><creatorcontrib>McEvoy, Mark A. ; Attia, John R. ; Oldmeadow, Christopher ; Holliday, Elizabeth ; Smith, Wayne T. ; Mangoni, Arduino A. ; Peel, Roseanne ; Hancock, Stephen J. ; Walker, Marjorie M. ; Talley, Nicholas J.</creatorcontrib><description>Background &amp; Aims Nitric oxide, a major inhibitory nonadrenergic, noncholinergic neurotransmitter that relaxes smooth muscle, may be implicated in the pathophysiology of visceral hypersensitivity in irritable bowel syndrome (IBS). Impaired bioavailability of the nitric oxide precursor molecule L‐arginine and higher concentrations of methylarginines (endogenous inhibitors of nitric oxide synthesis) are known to impair nitric oxide synthesis in numerous gastrointestinal cell types. We therefore examined serum concentrations of L‐arginine and the methylarginines in a nested case‐control study, to assess whether these factors are associated with adult IBS. Methods Data on clinical characteristics, methylarginines, and L‐arginine (measured using LC‐MS/MS) were collected from a random population‐based cohort of Australian adults (median age = 64 years; IQR = 60–70). Cases of IBS, defined according to Rome III criteria (N = 156), and controls (N = 332) were identified from within the cohort at the 5‐year follow‐up. Results In adjusted logistic regression analyses, L‐arginine, asymmetric dimethylarginine, symmetric dimethylarginine, L‐arginine/asymmetric dimethylarginine ratio, and Kessler‐10 psychological distress scores were significantly associated with IBS (p &gt; 0.05). Similar results were found for IBS subtypes. Higher serum L‐arginine concentration had the strongest association with IBS diagnosis, with an odds ratio of 9.03 for those with serum L‐arginine at the 75th (84 μmol/L) versus 25th (46 μmol/L) percentile (95% CI: 5.99–13.62). L‐arginine had the best discriminative ability with a bias‐adjusted area under the receiver operator characteristic curve of 0.859. Conclusions Higher serum concentrations of L‐arginine and endogenous methylarginines are strongly associated with IBS in adults.</description><identifier>ISSN: 2050-6406</identifier><identifier>EISSN: 2050-6414</identifier><identifier>DOI: 10.1002/ueg2.12137</identifier><identifier>PMID: 34431615</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Aged ; Aged, 80 and over ; Arginine - analogs &amp; derivatives ; Arginine - blood ; Asthma ; Bioavailability ; Biomarkers - blood ; Blood vessels ; Case-Control Studies ; Cohort Studies ; Enzymes ; Female ; Humans ; Inflammatory bowel disease ; Irritable bowel syndrome ; Irritable Bowel Syndrome - blood ; Irritable Bowel Syndrome - diagnosis ; Irritable Bowel Syndrome - psychology ; Logistic Models ; L‐arginine ; Male ; Mass spectrometry ; methylarginine ; Middle Aged ; Motility ; Neurogastroenterology ; Nitric oxide ; Nitric Oxide - biosynthesis ; Odds Ratio ; older adults ; Original ; Pathogenesis ; Pathophysiology ; Psychological Distress ; Questionnaires ; Risk factors ; ROC Curve ; Scientific imaging ; Smooth muscle</subject><ispartof>United European gastroenterology journal, 2021-09, Vol.9 (7), p.809-818</ispartof><rights>2021 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC. on behalf of United European Gastroenterology.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5157-9c6defb3c0aac5b3248618f905b3d938fafdb02f9c06da89711a7be2c9f81b1f3</citedby><cites>FETCH-LOGICAL-c5157-9c6defb3c0aac5b3248618f905b3d938fafdb02f9c06da89711a7be2c9f81b1f3</cites><orcidid>0000-0002-5505-5557</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435254/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3090900095?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11542,25732,27903,27904,36991,36992,44569,46031,46455,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34431615$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McEvoy, Mark A.</creatorcontrib><creatorcontrib>Attia, John R.</creatorcontrib><creatorcontrib>Oldmeadow, Christopher</creatorcontrib><creatorcontrib>Holliday, Elizabeth</creatorcontrib><creatorcontrib>Smith, Wayne T.</creatorcontrib><creatorcontrib>Mangoni, Arduino A.</creatorcontrib><creatorcontrib>Peel, Roseanne</creatorcontrib><creatorcontrib>Hancock, Stephen J.</creatorcontrib><creatorcontrib>Walker, Marjorie M.</creatorcontrib><creatorcontrib>Talley, Nicholas J.</creatorcontrib><title>Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study</title><title>United European gastroenterology journal</title><addtitle>United European Gastroenterol J</addtitle><description>Background &amp; Aims Nitric oxide, a major inhibitory nonadrenergic, noncholinergic neurotransmitter that relaxes smooth muscle, may be implicated in the pathophysiology of visceral hypersensitivity in irritable bowel syndrome (IBS). Impaired bioavailability of the nitric oxide precursor molecule L‐arginine and higher concentrations of methylarginines (endogenous inhibitors of nitric oxide synthesis) are known to impair nitric oxide synthesis in numerous gastrointestinal cell types. We therefore examined serum concentrations of L‐arginine and the methylarginines in a nested case‐control study, to assess whether these factors are associated with adult IBS. Methods Data on clinical characteristics, methylarginines, and L‐arginine (measured using LC‐MS/MS) were collected from a random population‐based cohort of Australian adults (median age = 64 years; IQR = 60–70). Cases of IBS, defined according to Rome III criteria (N = 156), and controls (N = 332) were identified from within the cohort at the 5‐year follow‐up. Results In adjusted logistic regression analyses, L‐arginine, asymmetric dimethylarginine, symmetric dimethylarginine, L‐arginine/asymmetric dimethylarginine ratio, and Kessler‐10 psychological distress scores were significantly associated with IBS (p &gt; 0.05). Similar results were found for IBS subtypes. Higher serum L‐arginine concentration had the strongest association with IBS diagnosis, with an odds ratio of 9.03 for those with serum L‐arginine at the 75th (84 μmol/L) versus 25th (46 μmol/L) percentile (95% CI: 5.99–13.62). L‐arginine had the best discriminative ability with a bias‐adjusted area under the receiver operator characteristic curve of 0.859. Conclusions Higher serum concentrations of L‐arginine and endogenous methylarginines are strongly associated with IBS in adults.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Arginine - analogs &amp; derivatives</subject><subject>Arginine - blood</subject><subject>Asthma</subject><subject>Bioavailability</subject><subject>Biomarkers - blood</subject><subject>Blood vessels</subject><subject>Case-Control Studies</subject><subject>Cohort Studies</subject><subject>Enzymes</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammatory bowel disease</subject><subject>Irritable bowel syndrome</subject><subject>Irritable Bowel Syndrome - blood</subject><subject>Irritable Bowel Syndrome - diagnosis</subject><subject>Irritable Bowel Syndrome - psychology</subject><subject>Logistic Models</subject><subject>L‐arginine</subject><subject>Male</subject><subject>Mass spectrometry</subject><subject>methylarginine</subject><subject>Middle Aged</subject><subject>Motility</subject><subject>Neurogastroenterology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - biosynthesis</subject><subject>Odds Ratio</subject><subject>older adults</subject><subject>Original</subject><subject>Pathogenesis</subject><subject>Pathophysiology</subject><subject>Psychological Distress</subject><subject>Questionnaires</subject><subject>Risk factors</subject><subject>ROC Curve</subject><subject>Scientific imaging</subject><subject>Smooth muscle</subject><issn>2050-6406</issn><issn>2050-6414</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNp9kc9qFTEUxoMottRufAAJuBHh1iST-RMXQim1LVxwoV2HTHLmNiWTXJOMZXauXfkIPouP4pOYdurFujBZ5MD58Z3z5UPoOSVHlBD2ZoINO6KMVu0jtM9ITVYNp_zxribNHjpM6ZqU03WcMf4U7VWcV7Sh9T769hHiNOL1r6_fVdxYbz1g5Q0Gb8IGfJgSHiFfzW7X1cFr8DmqbINPeBvBWJ2xjdFm1TvAfbgBh9PsTQwjYOuxMpPL6S0-_vnDQ8pgsFYJysiilWMocJ7M_Aw9GZRLcHj_HqDL96efTs5X6w9nFyfH65Wuad2uhG4MDH2liVK67ivGu4Z2gyClNqLqBjWYnrBBaNIY1YmWUtX2wLQYOtrToTpA7xbd7dSPYBYzTm6jHVWcZVBWPux4eyU34YvseFWzmheBV_cCMXyeiiE52qTBOeWhfJhkdcN5J1jbFPTlP-h1mKIv9mRFRLmEiLpQrxdKx5BShGG3DCXyNmV5m7K8S7nAL_5ef4f-ybQAdAFurIP5P1Ly8vSMLaK_AdVruJo</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>McEvoy, Mark A.</creator><creator>Attia, John R.</creator><creator>Oldmeadow, Christopher</creator><creator>Holliday, Elizabeth</creator><creator>Smith, Wayne T.</creator><creator>Mangoni, Arduino A.</creator><creator>Peel, Roseanne</creator><creator>Hancock, Stephen J.</creator><creator>Walker, Marjorie M.</creator><creator>Talley, Nicholas J.</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5505-5557</orcidid></search><sort><creationdate>202109</creationdate><title>Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study</title><author>McEvoy, Mark A. ; Attia, John R. ; Oldmeadow, Christopher ; Holliday, Elizabeth ; Smith, Wayne T. ; Mangoni, Arduino A. ; Peel, Roseanne ; Hancock, Stephen J. ; Walker, Marjorie M. ; Talley, Nicholas J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5157-9c6defb3c0aac5b3248618f905b3d938fafdb02f9c06da89711a7be2c9f81b1f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Arginine - analogs &amp; derivatives</topic><topic>Arginine - blood</topic><topic>Asthma</topic><topic>Bioavailability</topic><topic>Biomarkers - blood</topic><topic>Blood vessels</topic><topic>Case-Control Studies</topic><topic>Cohort Studies</topic><topic>Enzymes</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammatory bowel disease</topic><topic>Irritable bowel syndrome</topic><topic>Irritable Bowel Syndrome - blood</topic><topic>Irritable Bowel Syndrome - diagnosis</topic><topic>Irritable Bowel Syndrome - psychology</topic><topic>Logistic Models</topic><topic>L‐arginine</topic><topic>Male</topic><topic>Mass spectrometry</topic><topic>methylarginine</topic><topic>Middle Aged</topic><topic>Motility</topic><topic>Neurogastroenterology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - biosynthesis</topic><topic>Odds Ratio</topic><topic>older adults</topic><topic>Original</topic><topic>Pathogenesis</topic><topic>Pathophysiology</topic><topic>Psychological Distress</topic><topic>Questionnaires</topic><topic>Risk factors</topic><topic>ROC Curve</topic><topic>Scientific imaging</topic><topic>Smooth muscle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McEvoy, Mark A.</creatorcontrib><creatorcontrib>Attia, John R.</creatorcontrib><creatorcontrib>Oldmeadow, Christopher</creatorcontrib><creatorcontrib>Holliday, Elizabeth</creatorcontrib><creatorcontrib>Smith, Wayne T.</creatorcontrib><creatorcontrib>Mangoni, Arduino A.</creatorcontrib><creatorcontrib>Peel, Roseanne</creatorcontrib><creatorcontrib>Hancock, Stephen J.</creatorcontrib><creatorcontrib>Walker, Marjorie M.</creatorcontrib><creatorcontrib>Talley, Nicholas J.</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>United European gastroenterology journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McEvoy, Mark A.</au><au>Attia, John R.</au><au>Oldmeadow, Christopher</au><au>Holliday, Elizabeth</au><au>Smith, Wayne T.</au><au>Mangoni, Arduino A.</au><au>Peel, Roseanne</au><au>Hancock, Stephen J.</au><au>Walker, Marjorie M.</au><au>Talley, Nicholas J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study</atitle><jtitle>United European gastroenterology journal</jtitle><addtitle>United European Gastroenterol J</addtitle><date>2021-09</date><risdate>2021</risdate><volume>9</volume><issue>7</issue><spage>809</spage><epage>818</epage><pages>809-818</pages><issn>2050-6406</issn><eissn>2050-6414</eissn><abstract>Background &amp; Aims Nitric oxide, a major inhibitory nonadrenergic, noncholinergic neurotransmitter that relaxes smooth muscle, may be implicated in the pathophysiology of visceral hypersensitivity in irritable bowel syndrome (IBS). Impaired bioavailability of the nitric oxide precursor molecule L‐arginine and higher concentrations of methylarginines (endogenous inhibitors of nitric oxide synthesis) are known to impair nitric oxide synthesis in numerous gastrointestinal cell types. We therefore examined serum concentrations of L‐arginine and the methylarginines in a nested case‐control study, to assess whether these factors are associated with adult IBS. Methods Data on clinical characteristics, methylarginines, and L‐arginine (measured using LC‐MS/MS) were collected from a random population‐based cohort of Australian adults (median age = 64 years; IQR = 60–70). Cases of IBS, defined according to Rome III criteria (N = 156), and controls (N = 332) were identified from within the cohort at the 5‐year follow‐up. Results In adjusted logistic regression analyses, L‐arginine, asymmetric dimethylarginine, symmetric dimethylarginine, L‐arginine/asymmetric dimethylarginine ratio, and Kessler‐10 psychological distress scores were significantly associated with IBS (p &gt; 0.05). Similar results were found for IBS subtypes. Higher serum L‐arginine concentration had the strongest association with IBS diagnosis, with an odds ratio of 9.03 for those with serum L‐arginine at the 75th (84 μmol/L) versus 25th (46 μmol/L) percentile (95% CI: 5.99–13.62). L‐arginine had the best discriminative ability with a bias‐adjusted area under the receiver operator characteristic curve of 0.859. Conclusions Higher serum concentrations of L‐arginine and endogenous methylarginines are strongly associated with IBS in adults.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34431615</pmid><doi>10.1002/ueg2.12137</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-5505-5557</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2050-6406
ispartof United European gastroenterology journal, 2021-09, Vol.9 (7), p.809-818
issn 2050-6406
2050-6414
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8435254
source Wiley-Blackwell Open Access Collection; Publicly Available Content (ProQuest); PubMed Central
subjects Aged
Aged, 80 and over
Arginine - analogs & derivatives
Arginine - blood
Asthma
Bioavailability
Biomarkers - blood
Blood vessels
Case-Control Studies
Cohort Studies
Enzymes
Female
Humans
Inflammatory bowel disease
Irritable bowel syndrome
Irritable Bowel Syndrome - blood
Irritable Bowel Syndrome - diagnosis
Irritable Bowel Syndrome - psychology
Logistic Models
L‐arginine
Male
Mass spectrometry
methylarginine
Middle Aged
Motility
Neurogastroenterology
Nitric oxide
Nitric Oxide - biosynthesis
Odds Ratio
older adults
Original
Pathogenesis
Pathophysiology
Psychological Distress
Questionnaires
Risk factors
ROC Curve
Scientific imaging
Smooth muscle
title Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T23%3A06%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20L%E2%80%90arginine%20and%20endogenous%20methylarginine%20concentrations%20predict%20irritable%20bowel%20syndrome%20in%20adults:%20A%C2%A0nested%20case%E2%80%90control%20study&rft.jtitle=United%20European%20gastroenterology%20journal&rft.au=McEvoy,%20Mark%20A.&rft.date=2021-09&rft.volume=9&rft.issue=7&rft.spage=809&rft.epage=818&rft.pages=809-818&rft.issn=2050-6406&rft.eissn=2050-6414&rft_id=info:doi/10.1002/ueg2.12137&rft_dat=%3Cproquest_pubme%3E3090900095%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5157-9c6defb3c0aac5b3248618f905b3d938fafdb02f9c06da89711a7be2c9f81b1f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3090900095&rft_id=info:pmid/34431615&rfr_iscdi=true